Simplex Trading
KLDO

Simplex Trading’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Simplex Trading’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,800
Closed -$6K – 11885
2021
Q4 		$6K Hold
2,800
– – ﹤0.01% 9473
2021
Q3 		$21K Buy
2,800
+100
+4% +$620 ﹤0.01% 8435
2021
Q2 		$20K Buy
2,700
+2,567
+1,930% +$18.2K ﹤0.01% 8609
2021
Q1 		$107K Buy
+133
New +$1.45K ﹤0.01% 5656

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Simplex Trading's KLDO Position: Q2 2022 in Review

Simplex Trading sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 1,268 shares — an estimated $1.15K sold.

Simplex Trading first reported a position in KLDO in Q2 2021 and held it in 3 quarters. The position peaked at $5K in Q3 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Simplex Trading reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 1,268 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $1.15K.
  • Simplex Trading first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Simplex Trading's Kaleido Biosciences, Inc. Common Stock position peaked at $5K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.